Penis cancer, while thankfully rare, is experiencing a concerning increase in cases. Experts predict a 77% rise in penis cancer by 2050, with developing countries typically having the highest rates. However, even in most European countries, cases of penis cancer are on the rise. One of the main risk factors for developing penis cancer is being over the age of 50, and with Europe having an aging population, this presents a significant concern.
Various factors contribute to the development of penis cancer, including a narrowed foreskin, poor genital hygiene, and smoking tobacco. Notably, penis cancer is rare among individuals who have been circumcised at birth. Squamous cells in the skin of the penis are responsible for over 90% of penis cancers, with other malignancies such as melanoma, basal cell carcinoma, or sarcoma being less common. Additionally, human papillomaviruses (HPV) have been identified in about half of squamous cell cancer cases, indicating a strong link between HPV infections and the development of penis cancer.
HPV infections are primarily spread through skin contact and are one of the most commonly transmitted sexual infections. While infections often do not cause symptoms and can disappear over time without complications, they can persist just below the skin surface, leading to changes in skin texture and color known as “pre-malignant changes.” This can manifest as painless ulcers or warts on the glans and under the foreskin. HPV 16, the most common high-risk type of HPV, can trigger malignant changes in the tissues of various body parts, including the penis.
Unfortunately, diagnosing penis cancer is often delayed due to feelings of guilt or embarrassment among patients. Many men resort to self-medication with creams while avoiding seeing a doctor, leading to further delays in diagnosis. Additionally, some doctors misclassify lesions as benign, further delaying the diagnosis. Speedy diagnosis and treatment are crucial, particularly if cancerous cells have spread to the groin lymph glands, as the chances of a cure diminish significantly.
Cancerous tissue can be effectively removed through laser or micro-surgery, with the possibility of combining it with chemotherapy or radiotherapy. In cases where tumors do not respond well to treatment, amputation of the penis may be necessary – although this is always a last resort. Emerging approaches, such as engineered T cells that attack HPV-infected cells or immunotherapies that enhance immune responses to squamous cell tumors, have shown promising results in some cases.
The rise in penis cancer cases is a concerning trend that requires increased awareness, early diagnosis, and effective treatment options to combat effectively. Understanding the risk factors, causes, and available treatments is essential in addressing this growing health issue.
Leave a Reply